GENMAB A/S earnings
Annual earnings per share (USD per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $5.73 | $5.78 | 2026-09-02 13:19:08.731805 |
| 2025 | 2025-06-30 | $8.45 | $8.47 | 2026-09-02 13:19:08.731805 |
Revenue & profit (USD)
| Concept | 2026 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|
| Revenue | $2.05B | — | $1.64B |
| Profit for the year | $356.0M | — | $531.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in GENMAB A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in USD, as reported. Not investment advice.